BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23160998)

  • 1. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging.
    Van Laere K; Ahmad RU; Hudyana H; Celen S; Dubois K; Schmidt ME; Bormans G; Koole M
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):254-61. PubMed ID: 23160998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
    Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
    J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.
    Van Laere K; Koole M; Sanabria Bohorquez SM; Goffin K; Guenther I; Belanger MJ; Cote J; Rothenberg P; De Lepeleire I; Grachev ID; Hargreaves RJ; Bormans G; Burns HD
    J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Safety Evaluation and Human Dosimetry of [
    Koole M; Lohith TG; Valentine JL; Bennacef I; Declercq R; Reynders T; Riffel K; Celen S; Serdons K; Bormans G; Ferry-Martin S; Laroque P; Walji A; Hostetler ED; Briscoe RJ; de Hoon J; Sur C; Van Laere K; Struyk A
    Mol Imaging Biol; 2020 Feb; 22(1):173-180. PubMed ID: 31111397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
    Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
    Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [
    Delva A; Koole M; Serdons K; Bormans G; Liu L; Bard J; Khetarpal V; Dominguez C; Munoz-Sanjuan I; Wood A; Skinbjerg M; Wang Y; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):48-60. PubMed ID: 36001116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.
    Lin KJ; Hsu WC; Hsiao IT; Wey SP; Jin LW; Skovronsky D; Wai YY; Chang HP; Lo CW; Yao CH; Yen TC; Kung MP
    Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dosimetry of [
    Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
    Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
    Scheinin NM; Tolvanen TK; Wilson IA; Arponen EM; Någren KA; Rinne JO
    J Nucl Med; 2007 Jan; 48(1):128-33. PubMed ID: 17204709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.
    Sprague DR; Chin FT; Liow JS; Fujita M; Burns HD; Hargreaves R; Stubbs JB; Pike VW; Innis RB; Mozley PD
    J Nucl Med; 2007 Jan; 48(1):100-7. PubMed ID: 17204705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.
    Comley RA; Salinas C; Mizrahi R; Vitcu I; Ng A; Hallett W; Keat N; Wilson AA; Rabiner EA; Laruelle M; Houle S
    Mol Imaging Biol; 2012 Aug; 14(4):517-21. PubMed ID: 22076076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.